And other scholars conducted a comparative analysis between the impacts of IL-24 -engineered iMSCs (IL-24-iMSCs) and conventional iMSCs in melanoma, establishing that IL24-iMSCs exhibit superior efficacy in restraining melanoma growth compared to the control iMSCs (Liu B. et al., 2017). The gene discussed is IL24; the disease is melanoma.